Markov Modelling of Immunological and Virological States in HIV‐1 Infected Patients

The purpose of this study was to evaluate the evolution of HIV infected patients and to bring out some significant factors associated with this pathology. The main criteria revealing the State of illness is viral load measurement (VL). However the CD4 lymphocytes also represent an important marker as these reflect the State of the immune reservoir. Many studies have been carried out in this field and different models have been proposed with a view to a better understanding of this disease. Multi State Markov models defined in terms of CD4 counts, or in terms of viral load, have proved to be very useful tools for modelling HIV disease progression. The model we have developed in this study is based on both the CD4 lymphocytes counts and VL. Markov models are characterized by transition intensities. In this paper we explored several structures in succession. First, we used a homogeneous continuous time Markov process with four states defined by crossed values of CD4 and VL in a given patient at a given time. Then, the effect of certain covariates on the infection process was introduced into the model via the transition intensity functions, as with a Cox regression model. Since the hypothesis of homogeneity may be unrealistic in certain cases, we also considered piecewise homogeneous Markov models. Finally, the effects of covariates and time were combined in a piecewise homogeneous model with a covariate. We applied these methods to data from 1313 HIV-infected patients included in the NADIS cohort.

[1]  Juan Eloy Ruiz-Castro,et al.  A Multivariate Model to Measure the Effect of Treatments in Survival to Breast Cancer , 1998 .

[2]  I M Longini,et al.  The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. , 1991, Journal of acquired immune deficiency syndromes.

[3]  C Combescure,et al.  The analysis of asthma control under a Markov assumption with use of covariates , 2003, Statistics in medicine.

[4]  R Kay,et al.  A Markov model for analysing cancer markers and disease states in survival studies. , 1986, Biometrics.

[5]  Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution , 2001, Statistics in medicine.

[6]  J F Lawless,et al.  Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. , 1994, Statistics in medicine.

[7]  H. D. Miller,et al.  The Theory Of Stochastic Processes , 1977, The Mathematical Gazette.

[8]  J. Kalbfleisch,et al.  The Analysis of Panel Data under a Markov Assumption , 1985 .

[9]  Richard J Cook,et al.  A generalized mover-stayer model for panel data. , 2002, Biostatistics.

[10]  I M Longini,et al.  Use of immunological markers and continuous‐time Markov models to estimate progression of HIV infection in homosexual men , 1996, AIDS.

[11]  Ørnulf Borgan,et al.  Counting process models for life history data: a review , 1984 .

[12]  P Hougaard,et al.  Multi-state Models: A Review , 1999, Lifetime data analysis.

[13]  D. Costagliola,et al.  Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy , 2003, Journal of acquired immune deficiency syndromes.

[14]  L. Billard,et al.  A review and synthesis of the HIV/AIDS epidemic as a multi-stage process. , 1993, Mathematical biosciences.

[15]  Daniel Commenges,et al.  MKVPCI: a computer program for Markov models with piecewise constant intensities and covariates , 2001, Comput. Methods Programs Biomed..

[16]  D Commenges,et al.  Inference for multi-state models from interval-censored data , 2002, Statistical methods in medical research.

[17]  R H Jones,et al.  Multi-state models and diabetic retinopathy. , 1995, Statistics in medicine.

[18]  M A Fischl,et al.  Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel , 2000 .

[19]  J Grüger,et al.  The validity of inferences based on incomplete observations in disease state models. , 1991, Biometrics.

[20]  D Costagliola,et al.  Markov modelling of changes in HIV‐specific cytotoxic T‐lymphocyte responses with time in untreated HIV‐1 infected patients , 2003, Statistics in medicine.

[21]  Louise Ryan,et al.  A Three-state Multiplicative Model for Rodent Tumorigenicity Experiments , 1993 .